日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancing Anti-Tumor Effects of Engineered Extracellular Vesicles via Endocytosis Route Switching and Interferon Response Suppression.

通过胞吞途径转换和干扰素反应抑制增强工程化细胞外囊泡的抗肿瘤作用。

Huang Zixuan, Lu Chaoqun, Wang Yixin, Xian Huajian, Zheng Yuling, Kang Ting, Xiang Rufang, Xie Shufeng, Wang Minghui, Li Zeyi, Xia Xiaoli, Yu Yaoyifu, Zhang Wenjie, Zheng Huijian, Pan Renyao, Li Dan, Zhao Chunjun, Liu Han

Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia.

建立基于内质网应激相关细胞死亡基因的预后模型,并提出急性髓系白血病的新联合治疗方案

Wang Minghui, Xian Huajian, Xia Xiaoli, Zhang Wenjie, Huang Zixuan, Lu Chaoqun, Zheng Yuling, Wang Yixin, Xie Shufeng, Pan Renyao, Yu YaoYifu, Wang Ruiheng, Zheng Huijian, Huang Guorui, Liu Han

Correction: Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα-JNK pathway

更正:三氧化二砷和p97抑制剂通过靶向新生多肽并激活ZAKα-JNK通路,协同对抗急性髓系白血病。

Xie, Shufeng; Liu, Hui; Zhu, Shouhai; Chen, Zhihong; Wang, Ruiheng; Zhang, Wenjie; Xian, Huajian; Xiang, Rufang; Xia, Xiaoli; Sun, Yong; Long, Jinlan; Wang, Yuanli; Wang, Minghui; Wang, Yixin; Yu, Yaoyifu; Huang, Zixuan; Lu, Chaoqun; Xu, Zhenshu; Liu, Han